185 related articles for article (PubMed ID: 26254361)
1. Vessel and Mast Cell Densities in Sporadic and Syndrome-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Naber U; Glatzel M; Hagel C
Anticancer Res; 2015 Sep; 35(9):4713-22. PubMed ID: 26254361
[TBL] [Abstract][Full Text] [Related]
2. Vascular Innervation in Benign Neurofibromas of Patients with Neurofibromatosis Type 1.
Friedrich RE; Behrendt CA; Glatzel M; Hagel C
Anticancer Res; 2015 Dec; 35(12):6509-16. PubMed ID: 26637864
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
4. The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
Gesundheit B; Parkin P; Greenberg M; Baruchel S; Senger C; Kapelushnik J; Smith C; Klement GL
J Pediatr Hematol Oncol; 2010 Oct; 32(7):548-53. PubMed ID: 20686424
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
[TBL] [Abstract][Full Text] [Related]
7. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
Vasconcelos RAT; Guimarães Coscarelli P; Vieira TM; Noguera WS; Rapozo DCM; Acioly MA
Cancer Med; 2019 Mar; 8(3):972-981. PubMed ID: 30735009
[TBL] [Abstract][Full Text] [Related]
9. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
10. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract][Full Text] [Related]
11. Peripheral nerve sheath tumors arising in salivary glands: A clinicopathologic study.
Guraya SS; Prayson RA
Ann Diagn Pathol; 2016 Aug; 23():38-42. PubMed ID: 27402223
[TBL] [Abstract][Full Text] [Related]
12. Malignant Peripheral Nerve Sheath Tumor Arising Within Lumbar Spinal Plexiform Neurofibroma.
Alves Júnior SF; Pessoa Corrêa JA; Marchiori E
World Neurosurg; 2019 Oct; 130():264-266. PubMed ID: 31323411
[TBL] [Abstract][Full Text] [Related]
13. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
[TBL] [Abstract][Full Text] [Related]
14. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
15. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
16. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
17. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM; Rodriguez FJ
Neurosurgery; 2021 Feb; 88(3):443-456. PubMed ID: 33588442
[TBL] [Abstract][Full Text] [Related]
20. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
